Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone

Abstract

Following administration of the aldosterone receptor antagonist - spironolactone - the reversal of hypertension was not accompanied by the reduction of fibrosis in the left ventricle.